ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Epitopea Limited

Epitopea Limited is an active company incorporated on 23 April 2021 with the registered office located in Cambridge, Cambridgeshire. Epitopea Limited was registered 4 years ago.
Status
Active
Active since incorporation
Company No
13354764
Private limited company
Age
4 years
Incorporated 23 April 2021
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 22 April 2025 (9 months ago)
Next confirmation dated 22 April 2026
Due by 6 May 2026 (3 months remaining)
Last change occurred 8 months ago
Accounts
Due Soon
For period 1 May30 Apr 2024 (1 year)
Accounts type is Small
Next accounts for period 30 April 2025
Due by 31 January 2026 (5 days remaining)
Contact
Address
Salisbury House
Station Road
Cambridge
Cambridgeshire
CB1 2LA
United Kingdom
Same address since incorporation
Telephone
Unreported
Email
Unreported
People
Officers
5
Shareholders
20
Controllers (PSC)
1
Director • Venture Capitalist • American • Lives in United States • Born in Nov 1955
Director • Canadian • Lives in Canada • Born in May 1964
Director • Venture Capital Investor • British • Lives in UK • Born in Sep 1980
Director • Canadian • Lives in United States • Born in May 1965
Director • Canadian • Lives in Canada • Born in Apr 1952
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Immutrin Ltd
Michael Leith Anstey is a mutual person.
Active
Innovate Cambridge Ltd
Michael Leith Anstey is a mutual person.
Active
Trimtech Therapeutics Limited
Michael Leith Anstey is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2022–2024)
Period Ended
30 Apr 2024
For period 30 Apr30 Apr 2024
Traded for 12 months
Cash in Bank
£397.19K
Decreased by £355.83K (-47%)
Turnover
£210.65K
Increased by £7.03K (+3%)
Employees
10
Increased by 3 (+43%)
Total Assets
£1.23M
Decreased by £83.69K (-6%)
Total Liabilities
-£6.44M
Increased by £2.32M (+56%)
Net Assets
-£5.21M
Decreased by £2.41M (+86%)
Debt Ratio (%)
522%
Increased by 209.55% (+67%)
Latest Activity
Maxime Pesant Resigned
1 Month Ago on 17 Dec 2025
Confirmation Submitted
8 Months Ago on 8 May 2025
Small Accounts Submitted
11 Months Ago on 10 Feb 2025
Notification of PSC Statement
1 Year 5 Months Ago on 5 Aug 2024
Advent Life Sciences Llp (PSC) Resigned
1 Year 6 Months Ago on 18 Jul 2024
Dr Claude Wilfrid Perreault Appointed
1 Year 6 Months Ago on 18 Jul 2024
Confirmation Submitted
1 Year 8 Months Ago on 16 May 2024
Jonathan David Moore Resigned
2 Years 1 Month Ago on 22 Dec 2023
Mr Alan Rigby Appointed
2 Years 1 Month Ago on 22 Dec 2023
Full Accounts Submitted
2 Years 2 Months Ago on 22 Nov 2023
Get Credit Report
Discover Epitopea Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Termination of appointment of Maxime Pesant as a director on 17 December 2025
Submitted on 22 Dec 2025
Replacement filing of SH01 - 18/07/24 Statement of Capital gbp 2828.6577
Submitted on 26 Nov 2025
Information not on the register The material was formerly considered to form part of the register but is no longer considered by the registrar to do so.
Submitted on 20 May 2025
Confirmation statement made on 22 April 2025 with updates
Submitted on 8 May 2025
Second filing of a statement of capital following an allotment of shares on 19 September 2024
Submitted on 22 Apr 2025
Statement of capital following an allotment of shares on 8 April 2025
Submitted on 11 Apr 2025
Statement of capital following an allotment of shares on 5 January 2025
Submitted on 24 Feb 2025
Accounts for a small company made up to 30 April 2024
Submitted on 10 Feb 2025
Statement of capital following an allotment of shares on 23 October 2024
Submitted on 31 Oct 2024
Statement of capital following an allotment of shares on 19 September 2024
Submitted on 27 Sep 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year